ASH vs EXK

The Advanced Deterministic Scorecard reveals a deeply concerning financial profile with a Piotroski F-Score of just 2/9, indicating severe weakness in fundamental health. Despite a reasonable forward P/E of 13.53 and a 2.63% dividend yield, the company is plagued by a negative profit margin (-46.33%) and ROE (-34.45%), driven by a catastrophic earnings miss in Q3 2025. While the technical trend shows short-term recovery (+25.4% over 6M), long-term performance remains weak (-38.5% over 3Y), and analyst targets offer only marginal upside. Persistent earnings disappointment, lack of insider support, and deteriorating profitability undermine any value proposition.

Endeavour Silver Corp. presents a stark contrast between explosive top-line growth and deteriorating fundamental health, evidenced by a weak Piotroski F-Score of 2/9. While revenue growth is exceptional at 309.20% YoY and analysts maintain a 'strong_buy' rating with a target of $16.17, the company suffers from negative profit margins (-25.48%) and a consistent failure to meet earnings estimates (0/4 beats in the last year). The stock is currently trading at a high Price/Book multiple (4.92), suggesting a premium valuation that is not yet supported by bottom-line stability. The overall outlook is neutral as the bullish commodity-driven analyst sentiment clashes with severe deterministic health warnings.